{"transactions":[{"id":1373216,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":86264,"kind":"person","name":"KRANZLER JAY D","position":1,"cik":"0001055666","reported_name":"KRANZLER JAY D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK, PAR VALUE $0.0001","published_at":"2024-11-07T19:12:00.000Z","date":"2024-11-05","kind":"sale","planned":false,"acquired":false,"shares":61,"price":2.24,"value":136.64,"ownership":{"direct":true},"balance_after":559,"source":{"system":"sec-edgar","filing":"0001104659-24-115424","document":"tm2427866-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055666/000110465924115424/tm2427866-1_4seq1.xml","form_type":"4"}},{"id":1397084,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":86264,"kind":"person","name":"KRANZLER JAY D","position":1,"cik":"0001055666","reported_name":"KRANZLER JAY D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK, PAR VALUE $0.0001","published_at":"2024-10-01T16:15:13.000Z","date":"2024-09-30","kind":"purchase","planned":false,"acquired":true,"shares":497,"price":2.5,"value":1242.5,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Effective April 26, 2024, the Issuer effected a one-for-seventy-five reverse stock split of its common stock (the \"Reverse Stock Split\") and the amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Stock Split."}],"balance_after":620,"source":{"system":"sec-edgar","filing":"0001104659-24-104931","document":"tm2425333-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055666/000110465924104931/tm2425333-1_4seq1.xml","form_type":"4"}},{"id":1397083,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":86264,"kind":"person","name":"KRANZLER JAY D","position":1,"cik":"0001055666","reported_name":"KRANZLER JAY D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK, PAR VALUE $0.0001","published_at":"2024-10-01T16:15:13.000Z","date":"2024-09-27","kind":"purchase","planned":false,"acquired":true,"shares":3,"price":2.4,"value":7.2,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Effective April 26, 2024, the Issuer effected a one-for-seventy-five reverse stock split of its common stock (the \"Reverse Stock Split\") and the amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Stock Split."}],"balance_after":123,"source":{"system":"sec-edgar","filing":"0001104659-24-104931","document":"tm2425333-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055666/000110465924104931/tm2425333-1_4seq1.xml","form_type":"4"}},{"id":1399645,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":86264,"kind":"person","name":"KRANZLER JAY D","position":1,"cik":"0001055666","reported_name":"KRANZLER JAY D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee stock option (right to buy)","published_at":"2024-09-25T16:54:17.000Z","date":"2024-09-23","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in accordance with the following schedule: (i) one-third of the shares subject to the option vest on January 1, 2025; (ii) one-third of the shares subject to the option vest on January 1, 2026; and (iii) one-third of the shares subject to the option vest on January 1, 2027."}],"balance_after":30000,"derivative":{"exercise_price":2.46,"expiration_date":"2034-09-23","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-24-102835","document":"tm2424771-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055666/000110465924102835/tm2424771-3_4seq1.xml","form_type":"4"}},{"id":1837350,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":86264,"kind":"person","name":"KRANZLER JAY D","position":1,"cik":"0001055666","reported_name":"KRANZLER JAY D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee stock option (right to buy)","published_at":"2023-07-05T16:08:39.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in accordance with the following schedule: (i) one-third of the shares subject to the option vest on January 1, 2024; (ii) one-third of the shares subject to the option vest on January 1, 2025; and (iii) one-third of the shares subject to the option vest on January 1, 2026."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Effective September 22, 2022, the Issuer effected a one-for-fifteen reverse stock split of its common stock (the \"Reverse Stock Split\"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Stock Split."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Effective September 22, 2022, the Issuer effected a one-for-fifteen reverse stock split of its common stock (the \"Reverse Stock Split\"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Stock Split."}],"balance_after":100000,"derivative":{"exercise_price":1.14,"expiration_date":"2033-06-30","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001104659-23-078094","document":"tm2320488-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055666/000110465923078094/tm2320488-3_4seq1.xml","form_type":"4"}},{"id":2462974,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":86264,"kind":"person","name":"KRANZLER JAY D","position":1,"cik":"0001055666","reported_name":"KRANZLER JAY D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-21T16:26:28.000Z","date":"2021-12-17","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This restricted stock award (RSA) vests on March 15, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 85,668 shares of restricted stock."}],"balance_after":133683,"source":{"system":"sec-edgar","filing":"0001104659-21-152200","document":"tm2135922-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055666/000110465921152200/tm2135922-1_4seq1.xml","form_type":"4"}},{"id":2462973,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":86264,"kind":"person","name":"KRANZLER JAY D","position":1,"cik":"0001055666","reported_name":"KRANZLER JAY D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-21T16:26:28.000Z","date":"2021-12-17","kind":"grant","acquired":true,"shares":49020,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This restricted stock award (RSA) vests on December 17, 2024, three years after the date granted."}],"balance_after":113683,"source":{"system":"sec-edgar","filing":"0001104659-21-152200","document":"tm2135922-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055666/000110465921152200/tm2135922-1_4seq1.xml","form_type":"4"}},{"id":3109467,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":86264,"kind":"person","name":"KRANZLER JAY D","position":1,"cik":"0001055666","reported_name":"KRANZLER JAY D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-16T17:09:30.000Z","date":"2020-06-16","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Common Stock vests upon the earliest to occur of the following: (i) Grantee's death or disability; (ii) a change in control of Avenue Therapeutics, Inc.; or (iii) the Second Stage Closing with InvaGen."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 84,663 shares of restricted stock."}],"balance_after":84663,"source":{"system":"sec-edgar","filing":"0001104659-20-073825","document":"tm2022744d2_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055666/000110465920073825/tm2022744d2_form4.xml","form_type":"4"}},{"id":3427546,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":86264,"kind":"person","name":"KRANZLER JAY D","position":1,"cik":"0001055666","reported_name":"KRANZLER JAY D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-28T16:17:33.000Z","date":"2019-08-27","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Common Stock vests upon the earliest to occur of the following: (i) Grantee's death or disability; (ii) a change in control of Avenue Therapeutics, Inc.; or (iii) the Second Stage Closing with InvaGen."}],"balance_after":74663,"source":{"system":"sec-edgar","filing":"0001144204-19-042094","document":"tv528434_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055666/000114420419042094/tv528434_form4.xml","form_type":"4"}},{"id":3849958,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":86264,"kind":"person","name":"KRANZLER JAY D","position":1,"cik":"0001055666","reported_name":"KRANZLER JAY D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-08T21:43:49.000Z","date":"2018-08-07","kind":"gift","acquired":true,"shares":14663,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 14,663 shares of restricted common stock will vest on August 7, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 64,663 shares of restricted stock."}],"balance_after":64663,"source":{"system":"sec-edgar","filing":"0001144204-18-042956","document":"tv500467_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055666/000114420418042956/tv500467_form4.xml","form_type":"4"}}]}